Folic acid for the prevention of colorectal adenomas: A randomized clinical trial

JAMA

Volumn 297, Issue 21, 2007, Pages 2351-2359

  Cole, Bernard F ^a,b   Baron, John A ^b   Sandler, Robert S ^c   Haile, Robert W ^d   Ahnen, Dennis J ^e   Bresalier, Robert S ^g   McKeown Eyssen, Gail ^h   Summers, Robert W ^j   Rothstein, Richard I ^b   Burke, Carol A ^k   Snover, Dale C ^l   Church, Timothy R ^m   Allen, John I ^o   Robertson, Douglas J ^p   Beck, Gerald J ^k   Bond, John H ⁿ   Byers, Tim ^f   Mandel, Jack S ^q   Mott, Leila A ^b   Pearson, Loretta H ^b   Barry, Elizabeth L ^b   Rees, Judy R ^b   Marcon, Norman ⁱ   Saibil, Fred ⁱ   Ueland, Per Magne ^r   Greenberg, E Robert ^b   more..

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY OF IOWA   (United States)

^k LERNER RESEARCH INSTITUTE   (United States)

^l FAIRVIEW SOUTHDALE HOSPITAL   (United States)

^m UNIVERSITY OF MINNESOTA   (United States)

ⁿ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^o Minnesota Gastroenterology   (United States)

^p VA MEDICAL CENTER   (United States)

^q EMORY UNIVERSITY   (United States)

^r UNIVERSITY OF BERGEN   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEX RATIO; SIDE EFFECT; STROKE; TREATMENT OUTCOME; ADENOMA; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; COMPARATIVE STUDY; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PHASE 3 CLINICAL TRIAL; RISK; TREATMENT FAILURE;

ADENOMA; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RISK; TREATMENT FAILURE;

EID: 34249979299     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.21.2351     Document Type: Article

References (55)

1. Herbert V. Folic Acid. In: Shils M, Olson J, Shike M, Ross AC, eds. Nutrition in Health and Disease. Baltimore, Md: Williams & Wilkins; 1999.
2. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6:219-226.
3. Kim Y-I. Folate, colorectal carcinogenesis and DNA methylation: lessons from animal studies. Environ Mol Mutagen. 2004;44:10-25.
4. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002;132(suppl):2350S-2355S.
5. Harnack L, Jacobs DR, Nicodemus K, Lazovitch D, Anderson K, Folsom AR. Relationship of folate vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer. 2002;43:152-158.
6. Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst. 1993;85:875-884.
7. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995;87:265-273.
8. Peipins LA, Sandler RS. Epidemiology of colorectal adenomas. Epidemiol Rev. 1994;16:273-297.
9. Neugut AI, Jacobson JS, DeVivo I. Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev. 1993;2:159-176.
10. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891-899.
11. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med. 1998;129:517-524.
12. Mills JL. Fortification of foods with folic acid: how much is enough? N Engl J Med. 2000;342:1442-1445.
13. Snover DC. Serrated polyps of the large intestine. Semin Diagn Pathol. 2005;22:301-308.
14. Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol. 1997;281:43-53.
15. Kelleher BP, Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol. 1991;44:592-595.
16. Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem. 1989;35:260-264.
17. Windelberg A, Arseth O, Kvalheim G, Ueland PM. Automated assay for the determination of methylmalonic acid, total homocysteine, and related amino acids in human serum or plasma by means of methylchloroformate derivatization and gas chromatography-mass spectrometry. Clin Chem. 2005;51:2103-2109.
18. Little RJA, Rubin DB. Statistical Analysis With Missing Data. New York, NY: John Wiley & Sons; 1987.
19. Final Rule on Food Labeling, Health Claims and Label Statements, Folic Acid and Neural Tube Defects, 58 Federal Register 2606 (1993).
20. Food Standards: Amendment of the Standards of Identity for Enriched Grain Products to Require Addition of Folic Acid, 58 Federal Register 53305-53312 (1993).
21. Martínez ME, Giovannucci E, Jiang R, et al. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer. 2006;119:1440-1446.
22. Cravo ML, Mason JB, Dayal Y, et al. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res. 1992;52:5002-5006.
23. Kim Y-I, Salomon RN, Graeme-Cook F, et al. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut. 1996;39:732-740.
24. Le Leu RK, Young GP, McIntosh GH. Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis. 2000;21:2261-2265.
25. Song J, Medline A, Mason JB, Gallinger S, Kim Y-I. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res. 2000;60:5434-5440.
26. Wargovich MJ, Chen CD, Jimenez A, et al. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev. 1996;5:355-360.
27. Benito E, Cabeza E, Moreno V, Obrador A, Bosch FX. Diet and colorectal adenomas: a case-control study in Majorca. Int J Cancer. 1993;55:213-219.
28. Tseng M, Murray SC, Kupper LL, Sandler RS. Micronutrients and the risk of colorectal adenomas. Am J Epidemiol. 1996;144:1005-1014.
29. Baron JA, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst. 1998;90:57-62.
30. Breuer-Katschinski B, Nemes K, Marr A, et al; Colorectal Adenoma Study Group. Colorectal adenomas and diet: a case-control study. Dig Dis Sci. 2001;46:86-95.
31. Bird CL, Swendseid ME, Witte JS, et al. Red cell and plasma folate, folate consumption, and the risk of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev. 1995;4:709-714.
32. Whelan RL, Horvath KD, Gleason NR, et al. Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia. Dis Colon Rectum. 1999;42:212-217.
33. Paspatis GA, Kalafatis E, Oros L, Xourgias V, Koutsioumpa P, Karamanolis DG. Folate status and adenomatous colonic polyps: a colonoscopically controlled study. Dis Colon Rectum. 1995;38:64-67.
34. Kato I, Dnistrian AM, Schwartz M, et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer. 1999;79:1917-1921.
35. Martínez ME, Henning SM, Alberts DS. Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutr. 2004;79:691-697.
36. Glynn SA, Albanes D, Pietinen P, et al. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev. 1996;5:487-494.
37. Van Guelpen B, Hultdin J, Johansson I, et al. Low folate levels may protect against colorectal cancer. Gut. 2006;55:1461-1466.
38. Razin A, Cedar H. DNA methylation and gene expression. Microbiol Rev. 1991;55:451-458.
39. Pogribny IP, Basnakian AG, Miller BJ, Lopatina NG, Poirier LA, James SJ. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res. 1995;55:1894-1901.
40. Bedford MT, van Helden PD. Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res. 1987;47:5274-5276.
41. Gama-Sosa MA, Slagel VA, Trewyn RW, et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 1983;11:6883-6894.
42. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science. 1985;228:187-190.
43. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 1988;48:1159-1161.
44. Blount BC, Ames BN. DNA damage in folate deficiency. Baillieres Clin Haematol. 1995;8:461-478.
45. Kambara T, Simms LA, Whitehall VL, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137-1144.
46. Lonn E, Yusuf S, Arnold MJ, et al; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567-1577.
47. Stevens VL, Rodriguez C, Pavluck AL, McCullough ML, Thun MJ, Calle EE. Folate nutrition and prostate cancer incidence in a large cohort of US men [published online ahead of print March 22, 2006]. Am J Epidemiol. 2006;163:989-996.
48. Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P. Plasma folate, vitamin B12 and homocysteine and prostate cancer risk: a prospective study. Int J Cancer. 2005;113:819-824.
49. Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, et al. Null association between prostate cancer and serum folate, vitamin B6, vitamin B12 and homocysteine. Cancer Epidemiol Biomarkers Prev. 2003;12:1271-1272.
50. Pelucchi C, Galeone C, Talamini R, et al. Dietary folate and risk of prostate cancer in Italy. Cancer Epidemiol Biomarkers Prev. 2005;14:944-948.
51. Bills ND, Hinrichs SH, Morgan R, Clifford AJ. Delayed tumor onset in transgenic mice fed a low-folate diet. J Natl Cancer Inst. 1992;84:332-337.
52. Baggott JE, Vaughn WH, Juliana MM, Eto I, Krumdieck CL, Grubbs CJ. Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J Natl Cancer Inst. 1992;84:1740-1744.
53. Kotsopoulos J, Medline A, Renlund R, et al. Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis. 2005;26:1603-1612.
54. Charles D, Ness AR, Campbell D, Smith GD, Hall MH. Research pointers: taking folate in pregnancy and risk of maternal breast cancer. BMJ. 2004;329:1375-1376.
55. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2006;83:895-904.